Anavex Life Sciences Overview

Anavex Life Sciences EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AVXL.

Quarterly EBIT

-$6.78M

↑ 50.06% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$29.99M

↑ 63.16% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin